Mycophenolates in transplantation, Clinical Transplantation, vol.2, issue.5, pp.485-492, 2004. ,
DOI : 10.1046/j.1600-6143.2003.00321.x
MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS, Transplantation, vol.60, issue.3, pp.225-232, 1995. ,
DOI : 10.1097/00007890-199508000-00003
Mycophenolate mofetil and its mechanisms of action, Immunopharmacology, vol.47, issue.2-3, pp.85-118, 2000. ,
DOI : 10.1016/S0162-3109(00)00188-0
Effect of Mycophenolic Acid Glucuronide on Inosine Monophosphate Dehydrogenase Activity, Therapeutic Drug Monitoring, vol.19, issue.3, pp.358-360, 1997. ,
DOI : 10.1097/00007691-199706000-00018
Mechanism of Action of Mycophenolate Mofetil, Therapeutic Drug Monitoring, vol.17, issue.6, pp.681-684, 1995. ,
DOI : 10.1097/00007691-199512000-00023
Recombinant human inosine monophosphate dehydrogenase type I and type II proteins, Biochemical Pharmacology, vol.49, issue.9, pp.1323-1329, 1995. ,
DOI : 10.1016/0006-2952(95)00026-V
Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene, Journal of Clinical Investigation, vol.106, issue.4, pp.599-606, 2000. ,
DOI : 10.1172/JCI8669
Clinical Pharmacokinetics of Mycophenolate Mofetil, Clinical Pharmacokinetics, vol.34, issue.6, pp.429-455, 1998. ,
DOI : 10.2165/00003088-199834060-00002
Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil, Clinical Pharmacology & Therapeutics, vol.65, issue.6, pp.640-648, 1999. ,
DOI : 10.1016/S0009-9236(99)90085-1
Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients, J Am Soc Nephrol, vol.9, pp.1511-1520, 1998. ,
Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation, American Journal of Transplantation, vol.82, issue.1, pp.2496-2503, 2007. ,
DOI : 10.1097/00007691-200412000-00005
Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial, Transplantation, vol.86, issue.8, pp.1043-1051, 2008. ,
DOI : 10.1097/TP.0b013e318186f98a
Association of four DNA polymorphisms with acute rejection after kidney transplantation, Transplant International, vol.96, issue.9, pp.879-891, 2008. ,
DOI : 10.1111/j.1432-2277.2008.00679.x
A novel variant L263F in human inosine 5???-monophosphate dehydrogenase 2 is associated with diminished enzyme activity, Pharmacogenetics and Genomics, vol.17, issue.4, pp.283-290, 2007. ,
DOI : 10.1097/FPC.0b013e328012b8cf
Pharmacogenetics in Immunosuppressive Therapy, Therapeutic Drug Monitoring, vol.26, issue.4, pp.343-346, 2004. ,
DOI : 10.1097/00007691-200408000-00001
IMPDH1 Gene Polymorphisms and Association With Acute Rejection in Renal Transplant Patients, Clinical Pharmacology & Therapeutics, vol.10, issue.5, pp.711-717, 2008. ,
DOI : 10.1038/sj.clpt.6100347
An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients, Transplantation Proceedings, vol.36, issue.9, pp.2787-2790, 2004. ,
DOI : 10.1016/j.transproceed.2004.09.070
Expression of Inosine Monophosphate Dehydrogenase Type I and Type II After Mycophenolate Mofetil Treatment: A 2-year Follow-up in Kidney Transplantation, Clinical Pharmacology & Therapeutics, vol.14, issue.2, pp.328-335, 2008. ,
DOI : 10.1038/sj.clpt.6100300
Expression of IMPDH1 and IMPDH2 After Transplantation and Initiation of Immunosuppression, Transplantation, vol.85, issue.1, pp.55-61, 2008. ,
DOI : 10.1097/01.tp.0000296854.68123.03
Structure and Mechanism of Inosine Monophosphate Dehydrogenase in Complex with the Immunosuppressant Mycophenolic Acid, Cell, vol.85, issue.6, pp.921-930, 1996. ,
DOI : 10.1016/S0092-8674(00)81275-1
Crystal structure of human type II inosine monophosphate dehydrogenase: Implications for ligand binding and drug design, Proceedings of the National Academy of Sciences, vol.96, issue.7, pp.3531-3536, 1999. ,
DOI : 10.1073/pnas.96.7.3531
Isolation and Characterization of Mycophenolic Acid-resistant Mutants of Inosine-5'-monophosphate Dehydrogenase, Journal of Biological Chemistry, vol.272, issue.2, pp.961-965, 1997. ,
DOI : 10.1074/jbc.272.2.961
) Genetic Polymorphisms, Genetic Testing, vol.12, issue.4, pp.513-516, 2008. ,
DOI : 10.1089/gte.2008.0049
Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T>C polymorphism, Pharmacogenetics and Genomics, vol.19, issue.8, pp.626-634, 2009. ,
DOI : 10.1097/FPC.0b013e32832f5f1b
UGT1A9 -275T>A/-2152C>T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus-Treated Kidney Transplant Patients, Clinical Pharmacology & Therapeutics, vol.8, issue.3, pp.319-327, 2009. ,
DOI : 10.1097/00008571-200103000-00008
Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients, Pharmacogenetics and Genomics, vol.17, issue.5, pp.321-330, 2007. ,
DOI : 10.1097/FPC.0b013e32801430f8
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference, Therapeutic Drug Monitoring, vol.31, issue.2, pp.139-152, 2009. ,
DOI : 10.1097/FTD.0b013e318198d092
Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review, Transplantation, vol.85, issue.12, pp.1675-1685, 2008. ,
DOI : 10.1097/TP.0b013e3181744199
Monitoring of mycophenolic acid in pediatric renal transplant recipients, Transplantation Proceedings, vol.33, issue.1-2, pp.1040-1043, 2001. ,
DOI : 10.1016/S0041-1345(00)02322-8
The Weight of Pharmacokinetic Parameters for Mycophenolic Acid in Prediction of Rejection Outcome: The Receiver Operating Characteristic Curve Analysis, Transplantation Proceedings, vol.38, issue.1, pp.86-89, 2006. ,
DOI : 10.1016/j.transproceed.2005.11.084
Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients, RS-61443 Investigation Committee--Japan, pp.1421-1424, 1995. ,
The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy, J Am Soc Nephrol, vol.13, pp.759-768, 2002. ,
Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy, Clin Chem, vol.48, pp.517-525, 2002. ,